Creative Planning - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 133 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 3.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
Creative Planning ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$160,000
+88.2%
34,608
+52.3%
0.00%
Q4 2019$85,000
+1.2%
22,725
+44.3%
0.00%
Q3 2019$84,000
+211.1%
15,750
+47.5%
0.00%
Q3 2017$27,000
-6.9%
10,6810.0%0.00%
Q2 2017$29,000
+38.1%
10,6810.0%0.00%
Q1 2017$21,000
+16.7%
10,681
-36.0%
0.00%
Q4 2016$18,000
+50.0%
16,681
+56.2%
0.00%
Q3 2016$12,000
+20.0%
10,681
-27.7%
0.00%
Q2 2016$10,000
-37.5%
14,781
+6.9%
0.00%
Q1 2016$16,000
-69.2%
13,831
-34.7%
0.00%
Q4 2015$52,000
+100.0%
21,181
+141.2%
0.00%
Q3 2015$26,000
-27.8%
8,781
+6.7%
0.00%
Q1 2015$36,000
+28.6%
8,231
-12.0%
0.00%
Q4 2014$28,000
+3.7%
9,351
+13.6%
0.00%
Q3 2014$27,000
+28.6%
8,2310.0%0.00%
Q2 2014$21,000
+10.5%
8,2310.0%0.00%
Q1 2014$19,000
+18.8%
8,231
+0.6%
0.00%
Q4 2013$16,000
-36.0%
8,1810.0%0.00%
Q3 2013$25,000
+212.5%
8,181
-13.5%
0.00%
Q2 2013$8,0009,4550.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$1,902,0005.68%
GABLES CAPITAL MANAGEMENT INC. 433,814$5,566,0004.46%
Quantedge Capital Pte Ltd 503,700$6,462,0001.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,896,000$62,816,0001.25%
Lanham O'Dell & Company, Inc. 20,145$258,0000.92%
Capital Impact Advisors, LLC 59,301$907,0000.90%
SummerHaven Investment Management, LLC 98,840$1,268,0000.88%
Yorktown Management & Research Co Inc 50,000$642,0000.83%
GLOBEFLEX CAPITAL L P 304,293$3,904,0000.67%
AFFINITY INVESTMENT ADVISORS, LLC 90,864$1,166,0000.60%
View complete list of CATALYST PHARMACEUTICALS INC shareholders